Parents who are concerned about the heart risks of stimulants to treat attention deficit/hyperactivity disorder may hear conflicting advice from doctors, depending on whom they consult.
Last week, an advisory panel to the Food and Drug Administration voted 8-7 to suggest adding the agency’s strongest warning label to Ritalin, Adderall and similar medications. The panel based its decision on an FDA report that found 25 children and adults had died suddenly from 1999 to 2003 after taking ADHD drugs.
Steven Nissen, an advisory committee member, says many of the 4 million people who use the drugs may not realize that they have serious side effects. “I want parents and doctors, before they prescribe amphetamines and amphetamine-like drugs to children, to think a little harder whether they need them,” says Nissen, interim chairman of the Cleveland Clinic’s department of cardiovascular medicine.
(No Ratings Yet)
Loading ...You can leave a response, or trackback from your own site.
Links to This Article
FDA and ADHD Stimulant Medication. Science or Stigma? Part 1 (1/8/2009)
0 Comments to
“Mixed messages on ADHD”
Join the Conversation! Post a Comment:
Last reviewed: By John M. Grohol, Psy.D. on 17 Feb 2006
